{"assetProfile": {"address1": "555 Heritage Drive", "address2": "Suite 200", "city": "Jupiter", "state": "FL", "zip": "33458", "country": "United States", "phone": "858 550 7500", "website": "https://www.ligand.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Mr. Todd C. Davis Ph.D.", "age": 63, "title": "CEO & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": {"raw": 1342794, "fmt": "1.34M", "longFmt": "1,342,794"}, "exercisedValue": {"raw": 189892, "fmt": "189.89k", "longFmt": "189,892"}, "unexercisedValue": {"raw": 3684617, "fmt": "3.68M", "longFmt": "3,684,617"}}, {"maxAge": 1, "name": "Mr. Octavio  Espinoza", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": {"raw": 726930, "fmt": "726.93k", "longFmt": "726,930"}, "exercisedValue": {"raw": 174066, "fmt": "174.07k", "longFmt": "174,066"}, "unexercisedValue": {"raw": 2343180, "fmt": "2.34M", "longFmt": "2,343,180"}}, {"maxAge": 1, "name": "Mr. Andrew T. Reardon J.D.", "age": 49, "title": "Chief Legal Officer & Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": {"raw": 699330, "fmt": "699.33k", "longFmt": "699,330"}, "exercisedValue": {"raw": 483596, "fmt": "483.6k", "longFmt": "483,596"}, "unexercisedValue": {"raw": 1930213, "fmt": "1.93M", "longFmt": "1,930,213"}}, {"maxAge": 1, "name": "Mr. Paul J. Hadden", "title": "Senior Vice President of Investments & Business Development", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Keith  Marschke Ph.D.", "title": "Senior Vice President of Biology & Scientific Affairs", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Vincent D. Antle Ph.D.", "age": 55, "title": "Senior Vice President of Technical Operations & QA - Capitsol", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  Lucy", "title": "Senior VP & CBO Protein Expression Business", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Karen R. Reeves M.D.", "age": 73, "title": "Senior VP of Investments & Head of Clinical Strategy", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard B. Baxter", "title": "Senior VP of Investment Operation", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott M. Plesha", "age": 59, "title": "CEO of Pelthos Therapeutics", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investor.ligand.com/Investors/Investor-Overview/default.aspx", "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1762435800, "fmt": "2025-11-06"}], "earningsCallDate": [{"raw": 1762435800, "fmt": "2025-11-06"}], "isEarningsDateEstimate": false, "earningsAverage": {"raw": 1.88833, "fmt": "1.89"}, "earningsLow": {"raw": 1.6, "fmt": "1.60"}, "earningsHigh": {"raw": 2.09, "fmt": "2.09"}, "revenueAverage": {"raw": 58051000, "fmt": "58.05M", "longFmt": "58,051,000"}, "revenueLow": {"raw": 50147000, "fmt": "50.15M", "longFmt": "50,147,000"}, "revenueHigh": {"raw": 63700000, "fmt": "63.7M", "longFmt": "63,700,000"}}, "exDividendDate": {"raw": 1278028800, "fmt": "2010-07-02"}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-09-30", "growth": {"raw": 0.026300002, "fmt": "2.63%"}, "earningsEstimate": {"avg": {"raw": 1.88833, "fmt": "1.89"}, "low": {"raw": 1.6, "fmt": "1.6"}, "high": {"raw": 2.09, "fmt": "2.09"}, "yearAgoEps": {"raw": 1.84, "fmt": "1.84"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "growth": {"raw": 0.026300002, "fmt": "2.63%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 58051000, "fmt": "58.05M", "longFmt": "58,051,000"}, "low": {"raw": 50147000, "fmt": "50.15M", "longFmt": "50,147,000"}, "high": {"raw": 63700000, "fmt": "63.7M", "longFmt": "63,700,000"}, "numberOfAnalysts": {"raw": 7, "fmt": "7", "longFmt": "7"}, "yearAgoRevenue": {"raw": 51812000, "fmt": "51.81M", "longFmt": "51,812,000"}, "growth": {"raw": 0.1204, "fmt": "12.04%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 1.88833, "fmt": "1.89"}, "7daysAgo": {"raw": 1.92143, "fmt": "1.92"}, "30daysAgo": {"raw": 1.92143, "fmt": "1.92"}, "60daysAgo": {"raw": 1.92286, "fmt": "1.92"}, "90daysAgo": {"raw": 1.63833, "fmt": "1.64"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1q", "endDate": "2025-12-31", "growth": {"raw": 0.5984, "fmt": "59.84%"}, "earningsEstimate": {"avg": {"raw": 2.03, "fmt": "2.03"}, "low": {"raw": 1.92, "fmt": "1.92"}, "high": {"raw": 2.17, "fmt": "2.17"}, "yearAgoEps": {"raw": 1.27, "fmt": "1.27"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "growth": {"raw": 0.5984, "fmt": "59.84%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 61763140, "fmt": "61.76M", "longFmt": "61,763,140"}, "low": {"raw": 55840000, "fmt": "55.84M", "longFmt": "55,840,000"}, "high": {"raw": 67856000, "fmt": "67.86M", "longFmt": "67,856,000"}, "numberOfAnalysts": {"raw": 7, "fmt": "7", "longFmt": "7"}, "yearAgoRevenue": {"raw": 42812000, "fmt": "42.81M", "longFmt": "42,812,000"}, "growth": {"raw": 0.4427, "fmt": "44.27%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 2.03, "fmt": "2.03"}, "7daysAgo": {"raw": 2.04286, "fmt": "2.04"}, "30daysAgo": {"raw": 2.04286, "fmt": "2.04"}, "60daysAgo": {"raw": 2.04, "fmt": "2.04"}, "90daysAgo": {"raw": 1.785, "fmt": "1.78"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {"raw": -0.16790001, "fmt": "-16.79%"}, "earningsEstimate": {"avg": {"raw": 6.865, "fmt": "6.86"}, "low": {"raw": 6.75, "fmt": "6.75"}, "high": {"raw": 7.05, "fmt": "7.05"}, "yearAgoEps": {"raw": 8.25, "fmt": "8.25"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "growth": {"raw": -0.16790001, "fmt": "-16.79%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 212761140, "fmt": "212.76M", "longFmt": "212,761,140"}, "low": {"raw": 205369000, "fmt": "205.37M", "longFmt": "205,369,000"}, "high": {"raw": 218300000, "fmt": "218.3M", "longFmt": "218,300,000"}, "numberOfAnalysts": {"raw": 7, "fmt": "7", "longFmt": "7"}, "yearAgoRevenue": {"raw": 167133000, "fmt": "167.13M", "longFmt": "167,133,000"}, "growth": {"raw": 0.273, "fmt": "27.30%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 6.865, "fmt": "6.86"}, "7daysAgo": {"raw": 6.92286, "fmt": "6.92"}, "30daysAgo": {"raw": 6.92286, "fmt": "6.92"}, "60daysAgo": {"raw": 6.92143, "fmt": "6.92"}, "90daysAgo": {"raw": 6.13833, "fmt": "6.14"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {"raw": 0.0951, "fmt": "9.51%"}, "earningsEstimate": {"avg": {"raw": 7.518, "fmt": "7.52"}, "low": {"raw": 6.92, "fmt": "6.92"}, "high": {"raw": 8.1, "fmt": "8.1"}, "yearAgoEps": {"raw": 6.865, "fmt": "6.86"}, "numberOfAnalysts": {"raw": 5, "fmt": "5", "longFmt": "5"}, "growth": {"raw": 0.0951, "fmt": "9.51%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 239920170, "fmt": "239.92M", "longFmt": "239,920,170"}, "low": {"raw": 225377000, "fmt": "225.38M", "longFmt": "225,377,000"}, "high": {"raw": 255400000, "fmt": "255.4M", "longFmt": "255,400,000"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "yearAgoRevenue": {"raw": 212761140, "fmt": "212.76M", "longFmt": "212,761,140"}, "growth": {"raw": 0.1277, "fmt": "12.77%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 7.518, "fmt": "7.52"}, "7daysAgo": {"raw": 7.60667, "fmt": "7.61"}, "30daysAgo": {"raw": 7.60667, "fmt": "7.61"}, "60daysAgo": {"raw": 7.57667, "fmt": "7.58"}, "90daysAgo": {"raw": 7.03833, "fmt": "7.04"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {"raw": 1.84, "fmt": "1.84"}, "epsEstimate": {"raw": 1.34643, "fmt": "1.35"}, "epsDifference": {"raw": 0.49, "fmt": "0.49"}, "surprisePercent": {"raw": 0.3666, "fmt": "36.66%"}, "quarter": {"raw": 1727654400, "fmt": "2024-09-30"}, "currency": "USD", "period": "-4q"}, {"maxAge": 1, "epsActual": {"raw": 1.27, "fmt": "1.27"}, "epsEstimate": {"raw": 1.19014, "fmt": "1.19"}, "epsDifference": {"raw": 0.08, "fmt": "0.08"}, "surprisePercent": {"raw": 0.0671, "fmt": "6.71%"}, "quarter": {"raw": 1735603200, "fmt": "2024-12-31"}, "currency": "USD", "period": "-3q"}, {"maxAge": 1, "epsActual": {"raw": 1.33, "fmt": "1.33"}, "epsEstimate": {"raw": 1.2125, "fmt": "1.21"}, "epsDifference": {"raw": 0.12, "fmt": "0.12"}, "surprisePercent": {"raw": 0.09689999, "fmt": "9.69%"}, "quarter": {"raw": 1743379200, "fmt": "2025-03-31"}, "currency": "USD", "period": "-2q"}, {"maxAge": 1, "epsActual": {"raw": 1.6, "fmt": "1.6"}, "epsEstimate": {"raw": 1.42143, "fmt": "1.42"}, "epsDifference": {"raw": 0.18, "fmt": "0.18"}, "surprisePercent": {"raw": 0.12560001, "fmt": "12.56%"}, "quarter": {"raw": 1751241600, "fmt": "2025-06-30"}, "currency": "USD", "period": "-1q"}], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 191.24, "fmt": "191.24"}, "targetHighPrice": {"raw": 206.0, "fmt": "206.00"}, "targetLowPrice": {"raw": 164.0, "fmt": "164.00"}, "targetMeanPrice": {"raw": 182.14285, "fmt": "182.14"}, "targetMedianPrice": {"raw": 175.0, "fmt": "175.00"}, "recommendationMean": {"raw": 1.5, "fmt": "1.50"}, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": {"raw": 7, "fmt": "7", "longFmt": "7"}, "totalCash": {"raw": 245020000, "fmt": "245.02M", "longFmt": "245,020,000"}, "totalCashPerShare": {"raw": 12.503, "fmt": "12.5"}, "ebitda": {"raw": 19728000, "fmt": "19.73M", "longFmt": "19,728,000"}, "totalDebt": {"raw": 5742000, "fmt": "5.74M", "longFmt": "5,742,000"}, "quickRatio": {"raw": 4.594, "fmt": "4.59"}, "currentRatio": {"raw": 5.452, "fmt": "5.45"}, "totalRevenue": {"raw": 187584000, "fmt": "187.58M", "longFmt": "187,584,000"}, "debtToEquity": {"raw": 0.693, "fmt": "0.69%"}, "revenuePerShare": {"raw": 9.884, "fmt": "9.88"}, "returnOnAssets": {"raw": -0.00985, "fmt": "-0.99%"}, "returnOnEquity": {"raw": -0.094610006, "fmt": "-9.46%"}, "grossProfits": {"raw": 107790000, "fmt": "107.79M", "longFmt": "107,790,000"}, "freeCashflow": {"raw": 87922624, "fmt": "87.92M", "longFmt": "87,922,624"}, "operatingCashflow": {"raw": 55355000, "fmt": "55.35M", "longFmt": "55,355,000"}, "earningsGrowth": {}, "revenueGrowth": {"raw": 0.147, "fmt": "14.70%"}, "grossMargins": {"raw": 0.57462, "fmt": "57.46%"}, "ebitdaMargins": {"raw": 0.105170004, "fmt": "10.52%"}, "operatingMargins": {"raw": 0.20409, "fmt": "20.41%"}, "profitMargins": {"raw": -0.40443, "fmt": "-40.44%"}, "financialCurrency": "USD"}}